· Increasing speed of product availability, the Center will reduce time-to-market by 58 percent

· The center will facilitate the delivery of more than 3400 tons to the region.

Dubai: Bayer Middle East FZE has announced the launch of its regional distribution center that will reduce time-to-market by as much as 58 percent. The center will facilitate the delivery of more than 3400 tons annually, while ensuring greater network flexibility, increased frequency and dedicated stock for customers in the Middle East.

Supporting network optimization and streamlining supply, the warehouse is located in the Jebel Ali Free zone, close to the Jebel Ali Sea Port with easy connections to Al Maktoum International (DWC) and Dubai International (DXB) airports and major road arteries.

Equipped with the latest warehousing and cold chain technologies, the facility operated by Agility, one of the world's leading logistics companies, is spread over 60,000 m² with multiple storage temperature options. Accommodating over 100,000 pallet positions, 56 loading docks and 83 material handling equipment, the center is fully compliant with Ministry of Health, EU Guidelines on Good Distribution Practice and World Health Organization standards.

Thomas Panzer, SVP - Head Supply Chain Management Pharmaceuticals at Bayer AG said, “Customer focus is among Bayer’s core values and is embedded deeply in our overall supply chain strategy. With a presence in the Middle East for more than 85 years, we have been providing important healthcare and crop protection products to customers in the region. Within the last decade we have successfully launched various innovative products that advance the unmet health and nutritional needs of the region, which as the next step required us to invest in logistics infrastructure to ensure greater flexibility and reduce lead times.”

Henrik Wulff, Senior Bayer Representative – Middle East & Head of Bayer Pharmaceuticals Middle East added, “Advancing health and nutrition remains a priority for us. We want to ensure increased and closer product availability especially amidst COVID-19 through this center. Benefitting from Dubai’s strategic geographic location and logistics infrastructure and Agility’s experience, scale, operational capability and regional track record, the Center improves our distribution model in the Middle East and optimizes our last mile processes.”

Integrating fully with Agility’s warehouse management systems, Bayer will maintain visibility and traceability of inventory employing the latest technologies. The center will be supported by another facility that will be implemented in Germany in mid-2021 as part of Bayer’s long-term commitment to Middle East customers.

Albert Asool, CEO, Agility Dubai said, “Through this partnership we aim to support Bayer with world-class warehousing that incorporates multiple temperature-zone storage and cold-chain solutions. Our strategically positioned regional logistics hub, pharma supply chain expertise and distribution network incorporate a comprehensive suite of services, technologies and tools that provide visibility and traceability down to the unit level.”

The center is a key milestone for Bayer Middle East which as a legal entity was established in 2012 in the United Arab Emirates to cater the business of its leading divisions, Bayer Pharma, Bayer Consumer Health and Bayer Crop Science in the region including GCC countries and Egypt. Prior to the launch of the center, Bayer products were previously being directly imported into the local markets and sold to pharmacies, end consumers and patients through a distributor network.

About Agility

Agility is a global logistics company with $5.2 billion in annual revenue and 26,000 employees in more than 100 countries. It is one of the world’s top freight forwarding and contract logistics providers, and a leader and investor in technology to enhance supply chain efficiency. Agility is a pioneer in emerging markets and one of the largest private owners and developers of warehousing and light industrial parks in the Middle East, Africa and Asia. Agility’s subsidiary companies offer fuel logistics, airport services, commercial real estate and facilities management, customs digitization, and remote infrastructure services.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros. For more information, go to www.bayer.com.

For more information, please contact:
Sami Joost
Head of Communications / Public Affairs, Science & Sustainability (PASS) – Middle East
Email: sami.joost@bayer.com 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.